AHG
Akso Health Group
$1.56
+0.04 (+2.30%)
At close · Jul 7
Market Cap
$1.33B
Shares
854,043,910
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$14.78M
+512.1%
FY2025
Net Income
-$134.98M
-1327%
FY2025
Gross Margin
-1.91%
-7pp
FY2025
Operating Margin
-1125.37%
-767.6pp
FY2025
Diluted EPS
-$0.16
-128.6%
FY2025
Operating Cash Flow
$1.18M
-12.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| $14.78M | $2.41M | $13.18M | $6.31M | $1.75M | $11.44M | $61.33M | — | |
| — | — | — | — | — | — | — | $590.12K | |
| $15.06M | $2.29M | $11.91M | $5.39M | $544.57K | $4.99M | $7.4M | — | |
| -$281.53K | $122.13K | $1.27M | $916.23K | — | — | — | $107.26M | |
| -1.91% | 5.06% | 9.63% | 14.52% | — | — | — | — | |
| — | — | — | $421.19K | $441.41K | $3.16M | $1.15M | $2.82M | |
| $168.42K | $168.42K | $6661 | $240.93K | $1.09M | $16.47M | $32.32M | $15.24M | |
| $3.64M | $8.59M | $15.53M | $15M | $27.22M | $26.45M | $9.93M | $5.82M | |
| $3.64M | — | — | — | — | — | — | — | |
| $2.15M | — | — | — | — | — | — | — | |
| $2.15M | — | — | $18.39K | $15.16K | $580.5K | $406.8K | $174.38K | |
| $166.02M | $8.76M | $15.54M | $16.85M | — | — | — | $31.38M | |
| — | — | — | — | $32.66M | $79.96M | $56.23M | — | |
| -$166.3M | -$8.64M | -$14.27M | -$15.94M | -$30.9M | -$68.53M | $5.1M | $75.88M | |
| -1125.37% | -357.78% | -108.23% | -252.54% | -1761% | -599.28% | 8.31% | — | |
| -$164.15M | — | — | -$15.92M | -$30.89M | -$67.95M | $5.5M | $76.05M | |
| — | $804.14K | $804.14K | — | — | — | — | — | |
| $34.07K | -$453.75K | $1.2M | -$780.55K | -$164.92K | $1.6M | $2.31M | $660.88K | |
| -$166.27M | -$9.09M | -$13.07M | -$16.72M | -$31.07M | -$66.93M | $7.41M | $76.54M | |
| -$30.8M | $24.99K | $17.55K | $131.43K | $482.98K | $4.27M | $1.87M | $11.03M | |
| -$134.98M | -$9.46M | -$1.36M | -$16.85M | -$34.83M | -$71.2M | $5.53M | $65.48M | |
| -913.38% | -391.78% | -10.32% | -267.01% | -1984.52% | -622.63% | 9.02% | — | |
| -$491.76K | -$57.79K | $112.5K | $1331 | — | $28.65K | $28.65K | $28.65K | |
| — | — | — | — | — | -$71.2M | $5.53M | $65.48M | |
| -$135.15M | -$9.76M | -$3.45M | -$15.4M | -$30.88M | -$76.49M | -$603.61K | $71.41M | |
| USD/shares | -$0.16 | -$0.07 | -$0.02 | -$0.28 | -$0.71 | -$4.38 | $0.33 | $4.38 |
| USD/shares | -$0.16 | -$0.07 | -$0.02 | -$0.28 | -$0.71 | -$4.38 | $0.30 | $4.11 |
| shares | 855.29M | 141.52M | 68.6M | 59.61M | 48.84M | 16.25M | 16.23M | 14.99M |
| shares | 855.29M | 141.52M | 68.6M | 59.61M | 48.84M | 16.25M | 17.64M | 15.89M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2022: $9.32M in buybacks, $58.64M in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|
| Health Devices Segment | $6,000,000 | — | — |
| Online Market Place Segment | $311,092 | $1,754,935 | $6,914,474 |
By Product & Service (USD)
| Component | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|---|---|---|
| Revenue | $14,781,622 | $2,416,797 | $13,186,525 | — | — | — |
| Revenue from Marketing Promotion Service | $14,366,602 | — | — | — | — | — |
| Revenue from Sale of Medical Devices | $415,020 | $2,416,797 | $13,186,525 | — | — | — |
| Tax and Surcharges | -$3,824 | -$2,459 | -$4,964 | — | — | — |
| Commission Revenue | — | — | — | $96,332 | — | — |
| Commission Services | — | — | — | — | $82,054 | — |
| Interest Income1 | — | — | — | $215,393 | $1,690,448 | — |
| Interest | — | — | — | — | — | $3,043,096 |
| Other Revenues | — | — | — | — | — | $161,538 |
| Recommendation Service Revenues | — | — | — | — | — | $3,754,738 |
| Sale Of Medical Devices | — | $2,416,797 | $13,186,525 | $6,000,000 | — | — |
| Sales Of Medical Devices | — | — | $181,274 | — | — | — |
| Service Other | — | — | — | — | — | $3,916,276 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|
| Health Devices Segment | $567,171 | — | — |
| Online Market Place Segment | -$16,504,925 | -$30,904,348 | -$48,105,690 |
Operating Margin by Segment (%)
| Component | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|
| Health Devices Segment | 9.5% | — | — |
| Online Market Place Segment | -5305.5% | -1761% | -695.7% |